Abstract
Aim. To justify the application of the transscleral approach to hybrid photodynamic therapy for uveal melanoma based on experimental morphological research.
Materials and methods. In the first phase of the study, the penetration of laser photodynamic radiation through the sclerotic coat of a human cadaver eye was evaluated experimentally, followed by a morphological examination of the dissected scleral flap. In the second phase, a patient with stage T4aN0M0 IIIA ciliochoroidal melanoma of the left eye underwent hybrid photodynamic therapy two days prior to enucleation of the eyeball as a preventive measure against hematogenous metastases.
Results. Dosimetric control showed that optical light passes through the cadaveric sclerotic coat of the eye but suffers power loss, necessitating adjustments to the initial parameters to achieve an adequate therapeutic dose. Histological examination of the dissected scleral flaps (both lasered and intact) after transscleral photodynamic therapy showed no differences in the morphological structure of the two specimens. After hybrid photodynamic therapy in the patient with uveal melanoma, signs of partial thrombosis in the episcleral vessels at the base of the tumor and a decrease in the number of feeding intra-tumoral vessels were observed. Pathomorphological examination confirmed ciliochoroidal melanoma (spindle cell variant, type B, basal diameter - 1.7 cm, height - 1.7 cm) with minimal and maximal distances from the sclera to the necrotic zone of 0.3 mm and 0.5 mm, respectively, together with focal necroses and fibrin-erythrocytic thrombi in the lumens of some vessels, with a distance of 6.0 mm from the sclera to the vessel containing a fibrin-erythrocytic thrombus.
Conclusion. The prospects of using transscleral approaches in hybrid photodynamic therapy are supported by experimental morphological studies that have demonstrated the safe passage of laser photodynamic radiation through the sclerotic coat of the eye, as well as the development of necrotic changes and blood clots in the intra-tumoral vessels of ciliochoroidal melanoma after hybrid photodynamic therapy with chlorin-based photosensitizers. The findings provide justification for employing transscleral and hybrid approaches in photodynamic therapy as independent methods for organ-sparing treatment of uveal melanoma.
References
Damato B., Eleuteri A., Taktak A.F., Coupland S.E. Estimating prognosis for survival after treatment of choroidal melanoma. Progress in retinal and eye research. 2011; 30(5): 285-95.-DOI: 10.1016/j.preteyeres.2011.05.003.
Гришина Е.Е., Лернер М.Ю., Гемджян Э.Г. Эпидемиология увеальной меланомы в г. Москве. Альманах клинической медицины. 2017; 45(4): 321-325.-DOI: 10.18786/2072-0505-2017-45-4-321-325. [Grishina E.E., Lerner M.Y., Gemdzhyan E.G. Epidemiology of uveal melanomas in Moscow. Almanac of Clinical Medicine 2017; 45(4): 321-325.-DOI: 10.18786/2072-0505-2017-45-4-321-325 (In Rus)].
Бровкина А.Ф. Офтальмоонкология. М.: Медицина. 2002; 424 (илл). [Brovkina A.F. Ophthalmic oncology. M.: Medicine. 2002; 424(ill) (In Rus)].
Белый Ю.А., Терещенко А.В., Володин П.Л., et al. Морфологическое изучение фотодинамических эффектов с фотосенсибилизатором «Фотодитазин» на структуру меланомы сосудистой оболочки глаза человека. Вестник ОГУ. 2007; 78: 19-22.-URL: http://vestnik.osu.ru/doc/1033/article/4123/lang/0. [Beliy Yu.A., Tereshchenko A.V., Volodin P.L., et al. Morphological study of photodynamic effects with photosensitizer “Photoditazine” on the structure of melanoma of the human ocular vasculature. Vestnik OGU. 2007; 78: 19-22.-URL: http://vestnik.osu.ru/doc/1033/article/4123/lang/0 (In Rus.)].
Науменко Л.В. Пятилетние результаты комбинированного лечения пациентов с меланомой сосудистой оболочки глаза больших размеров. Здравоохранение. 2021; (8): 68-76. [Naumenko L.V. Five-year results of combined treatment of patients with melanoma of the ocular vasculature of large sizes. Zdravookhranenie. 2021; (8): 68-76 (In Rus)].
Странадко Е.Ф. Фотодинамическая терапия. Современное состояние проблемы. Лазерная медицина. 2021; 25(3S): 36. [Stranadko E.F. Photodynamic therapy. Current state of the problem. Laser Medicine. 2021; 25(3S): 36 (In Rus)].
Самкович Е.В., Панова И.Е., Бойко Э.В., Свистунова Е.М. Фотодинамическая терапия в комбинированном лечении меланомы хориоидеи. Вопросы онкологии. Материалы IX Петербургского международного онкологического форума «Белые ночи 2023. 2023; 69(3S): 505-507.-URL: https://voprosyonkologii.ru/index.php/journal/issue/view/62/31. [Samkovich E.V., Panova I.E., Boyko E.V., Svistunova E.M. Photodynamic therapy in the combined treatment of choroidal melanoma. Issues of oncology. Voprosy Onkologii = Problems in Oncology. Proceedings of the IX St. Petersburg International Cancer Forum "White Nights 2023. 2023; 69(3S): 505-507. -URL: https://voprosyonkologii.ru/index.php/journal/issue/view/62/31 (In Rus)].
Терещенко А.В., Белый Ю.А., Володин П.Л., Каплан М.А. Фотодинамическая терапия с фотосенсибилизатором «Фотодитазин» в офтальмологии. Под ред. проф. Х.П. Тахчиди. Калуга: МНТК «Микрохирургия глаза». 2008; 288(илл). [Tereshchenko A.V., Beliy Yг.A., Volodin P.L., Kaplan M.A. Photodynamic therapy with photosensitizer “Photoditazine” in ophthalmology. Ed. by Prof. H.P. Takhchidi. Kaluga: ISTC “Eye Microsurgery”. 2008; 288(ill) (In Rus)].
Тучин В.В. Лазеры и волоконная оптика в биомедицинских исследованиях. Изд. Саратовского университета. 1998: 384.-DOI: 10.23682/103652. [Tuchin V.V. Lasers and fiber optics in biomedical research. Ed. of Saratov University. 1998: 384.-DOI: 10.23682/103652 (In Rus)].
Schmidt-Erfurth U., Bauman W., Gragoudas E., et al. Photodynamic therapy of experimental choroidal melanoma using lipoprotein-delivered benzoporphyrin. Ophthalmology. 1994; 101(1): 89-99.
Бойко Э.В., Шишкин М.М., Сухотерина Е.Г., Куликов А.Н. Возможности диодлазерной транссклеральной ретинопексии (в сравнении с криопексией) в витреоретинальной хирургии. Офтальмохирургия и терапия. 2001; 1(1): 47-52. [Boyko E.V., Shishkin M.M., Sukhoterin E.G., Kulikov A.N. Possibilities of diode laser transscleral retinopexy (in comparison with cryopexy) in vitreoretinal surgery. Ophthalmosurgery & Therapeutics. 2001; 1(1): 47-52 (In Rus)].
Бойко Э.В., Панова И.Е., Самкович Е.В. Способ органосохраняющего лечения меланомы хориоидеи на основе применения гибридной фотодинамической терапии. Патент РФ на изобретение No. 2785609/ 09.12.2022. Bulletin No. 34.-URL: https://fips.ru/registers-doc-view/fips_servlet (01.06.2023). [Boyko E.V., Panova I.E., Samkovich E.V. Sposob organosohranyayushchego lecheniya melanomy horioidei na osnove primeneniya gibridnoj fotodinamicheskoj terapii. Patent RUS № 2785609/ 09.12.2022. Byul. № 34.-URL: https://fips.ru/registers-doc-view/fips_servlet (01.06.2023) (In Rus)].
Лихванцева В.Г., Акопян В.С., Султанова Э.О. Способ органосохраняющего лечения внутриглазных опухолей. Патент РФ на изобретение № 2452444 / 10.06.2012. Бюл. № 16. [Likhvantseva V.G., Hakobyan V.S., Sultanova E.O. Method of organ preserving treatment of intraocular tumors. Russian Federation patent for invention № 2452444 / 10.06.2012. Bulletin No. 16 (In Rus)].
Castellani A., Pace G.P., Concioli M.J. Photodynamic effect of hematoporphyrin on blood circulation. J Path Bact. 1963; 86: 99-102.
Клинические рекомендации Министерства здравоохранения Российской Федерации «Увеальная меланома». 2020.-URL: https://cr.minzdrav.gov.ru/clin-rec [Clinical recommendations of the Ministry of Health of the Russian Federation "Uveal melanoma". 2020.-URL: https://cr.minzdrav.gov.ru/clin-rec (In Rus)].
Berezin Yu.D., Eremenko S.A., Boiko E.V. Monte Carlo method in the mathematical simulation of the laser-induced transscleral hyperthermia of intraocular neoplasms. J Opt Technol. 2000; 67: 247.
Berezin Y.D., Eremenko S.A., Malinin B.G., et al. (1999). Experimental study of endoscleral and transscleral actions of IR radiation of diode, neodymium, and holmium lasers on the retina of the eye. J Opt Technol. 1999; 66(12): 1040.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© АННМО «Вопросы онкологии», Copyright (c) 2025